Acetylserotonin O-methyltransferase

From WikiMD's WELLNESSPEDIA

File:FIG4.png
Acetylserotonin O-methyltransferase

Acetylserotonin O-methyltransferase (ASMT), also known as hydroxyindole O-methyltransferase (HIOMT), is an enzyme that plays a crucial role in the biosynthesis of melatonin, a hormone that regulates circadian rhythms and sleep-wake cycles in humans and other animals.

Function[edit]

ASMT catalyzes the final step in the synthesis of melatonin from serotonin. Specifically, it transfers a methyl group from S-adenosyl methionine (SAM) to N-acetylserotonin, converting it into melatonin. This reaction is essential for the production of melatonin in the pineal gland, particularly during the night when melatonin synthesis is at its peak.

Structure[edit]

ASMT is a member of the methyltransferase family of enzymes. It is characterized by a conserved SAM-dependent methyltransferase domain, which is responsible for binding SAM and facilitating the transfer of the methyl group. The enzyme's structure allows it to specifically recognize and bind to its substrate, N-acetylserotonin, ensuring the precise conversion to melatonin.

Regulation[edit]

The activity of ASMT is regulated by various factors, including the availability of its substrates, SAM and N-acetylserotonin, and the expression of the ASMT gene. The enzyme's activity is also influenced by circadian clock genes, which help synchronize melatonin production with the day-night cycle.

Clinical Significance[edit]

Alterations in ASMT activity can affect melatonin levels, potentially leading to sleep disorders and other circadian rhythm-related issues. Research has also suggested a link between ASMT gene polymorphisms and certain psychiatric disorders, such as autism spectrum disorder and bipolar disorder.

Related Enzymes[edit]

ASMT is part of a broader pathway involving several other enzymes, including:

Related pages[edit]